[Results of combined 133 Xe-MAP lung scintigraphy in bronchial carcinoma. Retrospective and prospective study].
D000236:Adenoma / Q000175:diagnosis; D000328:Adult; D001984:Bronchial Neoplasms / Q000175:diagnosis*; D001987:Bronchiectasis / Q000175:diagnosis; D002276:Carcinoid Tumor / Q000175:diagnosis; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis; D004443:Echinococcosis / Q000175:diagnosis; D005189:False Positive Reactions; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011446:Prospective Studies; D011655:Pulmonary Embolism / Q000175:diagnosis; D011656:Pulmonary Emphysema / Q000175:diagnosis; D011877:Radionuclide Imaging; D012189:Retrospective Studies; D013667:Technetium; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis; D014978:Xenon
D014978:Xenon; D013667:Technetium
Ergebuisse der kombinierten Xe-MAP-Lungenszintigraphic beim Bronchialkarzinom. Eline restrospektive and prospektive Studie.